Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Velasco

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
American Journal of Therapeutics|September 27, 2012
Obesity genetics: a monopoly game of genesJoselyn Rojas, Miguel Aguirre, Manuel Velasco, et al.
Critical Care Nursing Clinics of North America|May 14, 2020
Humanizing Intensive Care: From Theory to PracticeJosé Manuel Velasco Bueno, Gabriel Heras La Calle
American Journal of Therapeutics|November 19, 2003
The actions of dopamine on the airwaysGloria A Cabezas, Zafar H Israili, Manuel Velasco
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug ReleaseNarsimha Mamidi, Ramiro Manuel Velasco Delgadillo, Enrique V Barrera
Materials Science & Engineering. C, Materials for Biological Applications|February 6, 2021
Engineering of carbon nano-onion bioconjugates for biomedical applicationsNarsimha Mamidi, Ramiro Manuel Velasco Delgadillo, Aldo González-Ortiz
Journal of Obesity|February 15, 2011
AMPK as Target for Intervention in Childhood and Adolescent ObesityJoselyn Rojas, Nailet Arraiz, Miguel Aguirre, et al.
Dermatology Online Journal|March 11, 2008
Familial necrobiosis lipoidica not associated with diabetesElena Roche-Gamón, Juan J Vilata-Corell, Manuel Velasco-Pastor
American Journal of Therapeutics|August 2, 2007
Metabolic syndrome: treatment of hypertensive patientsZafar H Israili, Badiâa Lyoussi, Rafael Hernández-Hernández, et al.
Current Hypertension Reports|August 1, 2012
Targeting hypertension in patients with cardiorenal metabolic syndromeEdward Rojas, Manuel Velasco, Valmore Bermúdez, et al.
American Journal of Therapeutics|July 1, 1995
Cardiovascular and Hormonal Effects of Domperidone, A Peripheral Dopaminergic Blocker, in Bromocriptine-Treated Hypertensive PatientsManuel Velasco, Ramón Arreaza, Augusta Luchsinger, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
American Journal of Therapeutics|September 27, 2012
Obesity genetics: a monopoly game of genesJoselyn Rojas, Miguel Aguirre, Manuel Velasco, et al.
Critical Care Nursing Clinics of North America|May 14, 2020
Humanizing Intensive Care: From Theory to PracticeJosé Manuel Velasco Bueno, Gabriel Heras La Calle
American Journal of Therapeutics|November 19, 2003
The actions of dopamine on the airwaysGloria A Cabezas, Zafar H Israili, Manuel Velasco
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug ReleaseNarsimha Mamidi, Ramiro Manuel Velasco Delgadillo, Enrique V Barrera
Materials Science & Engineering. C, Materials for Biological Applications|February 6, 2021
Engineering of carbon nano-onion bioconjugates for biomedical applicationsNarsimha Mamidi, Ramiro Manuel Velasco Delgadillo, Aldo González-Ortiz
Journal of Obesity|February 15, 2011
AMPK as Target for Intervention in Childhood and Adolescent ObesityJoselyn Rojas, Nailet Arraiz, Miguel Aguirre, et al.
Dermatology Online Journal|March 11, 2008
Familial necrobiosis lipoidica not associated with diabetesElena Roche-Gamón, Juan J Vilata-Corell, Manuel Velasco-Pastor
American Journal of Therapeutics|August 2, 2007
Metabolic syndrome: treatment of hypertensive patientsZafar H Israili, Badiâa Lyoussi, Rafael Hernández-Hernández, et al.
Current Hypertension Reports|August 1, 2012
Targeting hypertension in patients with cardiorenal metabolic syndromeEdward Rojas, Manuel Velasco, Valmore Bermúdez, et al.
American Journal of Therapeutics|July 1, 1995
Cardiovascular and Hormonal Effects of Domperidone, A Peripheral Dopaminergic Blocker, in Bromocriptine-Treated Hypertensive PatientsManuel Velasco, Ramón Arreaza, Augusta Luchsinger, et al.
Pageof 11